NOX 1.52% 6.7¢ noxopharm limited

Veyonda pricing?Is there a chance that NOXCOVID if successful,...

  1. 424 Posts.
    lightbulb Created with Sketch. 206

    Veyonda pricing?


    Is there a chance that NOXCOVID if successful, could undermine the price set point for Veyonda if it becames an approved oncology drug?


    Here’s an article that talks about pricing a drug during a pandemic and companies being seen to maximize profits. In pricing Veyonda for COVID-19 treatment, it would be hard to then turn around and charge a different price for the same drug in an oncology setting.


    https://www.ajmc.com/view/gilead-sciences-sets-us-price-for-covid19-drug-at-2340-to-3120-based-on-insurance


    All of this only matters if Veyonda is successful on both fronts but hopefully Noxopharm are able to do the right thing by both potential patients and investors alike.

 
watchlist Created with Sketch. Add NOX (ASX) to my watchlist
(20min delay)
Last
6.7¢
Change
0.001(1.52%)
Mkt cap ! $19.28M
Open High Low Value Volume
6.7¢ 6.7¢ 6.7¢ $818 12.21K

Buyers (Bids)

No. Vol. Price($)
1 17790 6.7¢
 

Sellers (Offers)

Price($) Vol. No.
7.0¢ 4049 1
View Market Depth
Last trade - 15.44pm 12/07/2024 (20 minute delay) ?
NOX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.